TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ILLUMINA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ILLUMINA

ST13

US500000085648638

Class

1, 9, 40, 42

Filing

85648638

Registration

4268307

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

11/05/2025

Classification

Registered

Trademark type

Word

Nice classes

1, 9, 40, 42

Filing date

06/11/2012

Registration date

01/01/2013

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/07/2023

Last transaction

11/05/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

02/23/2001

First use in commerce

02/23/2001

Drawing code

4

Owner type

03

Owner location

San Diego, CA

Examiner

CROSS,TRACY L

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Illumina, Inc.

Representatives

Susan M. Natland Baker & Hostetler LLP

Technical classification

Nice Classes

Class 1Class 9Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Assays and reagents for use in genetic research; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagent kits comprised primarily of oligonucleotides, enzymes, antibodies, dyes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research

Class 9

Automated laboratory apparatus and computer systems for use in analysis of biomolecules; nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in the analysis of biomolecules, and analyzers for use in scientific research; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; computer systems, namely, computer hardware, computer software, and data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific research; computer software for data collection, management, and analysis of genetic information for use in the field of scientific research

Class 40

Custom synthesis services, namely, custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof and custom nucleotide attachment to substrates

Class 42

Scientific research; medical research; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and research related thereto; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; consulting services in the field of cloud computing in the fields of life science; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research

Publications

History of USPTO decisions and trademark events.

46 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

10/29/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/29/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/29/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/29/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/29/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/29/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/07/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/07/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/07/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

12/12/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/01/2022

NOSU

NOTICE OF SUIT

01/15/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/21/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/21/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/31/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/31/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/23/2019

E815

TEAS SECTION 8 & 15 RECEIVED

12/20/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/01/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/21/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/21/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/20/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/20/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/15/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/31/2014

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/31/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

01/01/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/16/2012

PUBO

PUBLISHED FOR OPPOSITION

10/16/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/26/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/13/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

09/06/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/05/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

09/05/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/05/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/12/2012

GNRT

NON-FINAL ACTION E-MAILED

08/12/2012

CNRT

NON-FINAL ACTION WRITTEN

08/12/2012

DOCK

ASSIGNED TO EXAMINER

07/27/2012

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

07/19/2012

ALIE

ASSIGNED TO LIE

07/06/2012

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

06/24/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/20/2012

NWAP

NEW APPLICATION ENTERED

06/14/2012

Continuous trademark protection

Get notified about every new filing that threatens ILLUMINA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.